Fluids
Patients with anuria depend on extrarenal mechanisms for water excretion and therefore readily develop water intoxication.
The average daily extrarenal loss of water in adults in temperate climates is about 1000 ml due to insensible losses from skin, lungs and in faeces. This is partly replaced by water of oxidation from tissue metabolism (300 ml) and pre-formed tissue water liberated during metabolism (125 ml) leaving some 500 ml to be supplied daily by fluid and dietary intake (Bluemle, Potter & Elkinton, 1956) . Early regimens, such as that of Bull, Joekes & Lowe (1949) , recommended a fluid intake of 800-1000 ml daily. This was sufficient to prevent weight loss and gradually produced overhydration with development of hyponatraemia (Loughridge et al., 1960) . This overhydration explains early reports of increased extracellular fluid volume in uraemic patients (Sirota & Kroop, 1951; Bluemle et al., 1956) .
The present view is that the daily fluid requirement of adults with acute renal failure in temperate climates is some 400 ml plus the volume of any sensible fluid loss (Merrill, 1965) . The simplest index of fluid balance is daily weight loss which should average 200-500 g daily (Swan & Merrill, 1953) . In addition plasma sodium can be monitored and should remain relatively constant. A fall in plasma sodium suggests overhydration, and the treatment of hyponatraemia in these circumstances is further limitation of fluid intake rather than infusion of sodium chloride.
In centres with a policy of early dialysis using an artificial kidney capable of ultrafiltration, a more liberal fluid intake is permissible, provided excessive overhydration is avoided.
Sodium and chloride
Extrarenal losses of sodium and chloride are small in the anuric patient and there should be little change in plasma sodium and chloride levels. Hyponatraemia and hypochloraemia represent over-hydration due to excessive water intake. Routine sodium replacement is not required unless there are obvious losses, and if sodium salts are given for other purposes (e.g. intravenous sodium bicarbonate for acidosis) care must be taken to avoid circulatory overloading and pulmonary oedema.
Potassium
Potassium is released from depleted glycogen stores, destruction of tissue protein, intravascular haemolysis, destruction of blood extravasated into tissues and the shift of potassium from within the cells due to progressive metabolic acidosis (Keating et al., 1953) . Whatever the mechanism of potassium release potassium intoxication may result. This is related partly to the serum potassium levels and also to associated hyponatraemia, hypocalcaemia, hyper-Acute reversible intrinsic renalJailure magnesaemia, and acidosis. As a result toxic effects on both cardiac and skeletal muscle may develop.
Electrocardiographic changes do not correlate precisely with serum potassium levels but nevertheless follow a predictable pattern and, as they represent changes occurring in the cardiac conducting system, are the best monitor of potassium intoxication (Merrill et al., 1950) . Lengthening of the PR interval, peaking of the Twave, and flattening of the P wave occur early and as these changes become more prominent the QRS complex widens. Later the ST segment merges with the upstroke of the T wave and ultimately there may develop a sine-wave pattern followed finally by cardiac arrest.
Occasionally muscular weakness, leading to paralyses, including respiratory paralysis, is observed and usually indicates severe potassium intoxication requiring urgent treatment.
Prevention of potassium intoxication includes potassium-free diets, adequate surgical debridement and drainage, minimizing protein catabolism by treatment of infection, and providing an adequate calorie intake. In addition any blood transfused should be not more than a few days old.
If the serum potassium level is more than 7 mEq/l the most rapid treatment, acting within minutes, is infusion of hypertonic sodium bicarbonate. The sodium ion antagonizes the cardiac effects of potassium and also potassium returns intra-cellularly as a result of treatment of the acidosis (Keating et al., 1953) . These effects are short-lived (1-2 hr) and must be reinforced by exchange resins or dialysis. Other slower emergency treatments include infusion of 200 ml of hypertonic (5%) sodium chloride or 100 ml of 10% calcium gluconate (Meroney & Herndon, 1954) or most commonly infusion of hypertonic glucose together with insulin (100-200 ml 50% glucose + 20 units soluble insulin) in order to deposit glycogen with associated potassium and phosphate into the cells (Merrill et al., 1950) . This last treatment is rather slow in onset (j-1 hr) but its effect may last for several hours.
These emergency measures should be reinforced by the use of cation-exchange resins either orally or per rectum. Originally an ammonium cycle resin (Elkinton et al., 1951) or a sodium cycle resin (Evans et al., 1953) were used. More recently a palatable fine-mesh resin in the sodium cycle (Resonium A) has been developed which can be given orally in dosage of up to 100 g sometimes together with sorbitol (Flinn, Merrill & Welzant, 1961) . The latter is a poorly absorbed osmoticallyactive alcohol which accelerates gastro-intestinal emptying. Sorbitol therefore facilitates water, sodium and potassium loss by diarrhoea, and simultaneously the resin exchanges sodium for potassium, replacing sodium lost by action of the sorbitol.
Alternatively a resin in the calcium phase may be given prophylactically in a daily dose of say 50 g orally (Berlyne et al., 1966 Early studies in normal people suggested the optimal quantity of carbohydrate for protein sparing was 100 g daily and Butler et al. (1945) and Gamble (1947) believed that nitrogen production was not significantly affected by further increasing carbohydrate intake.
Borst (1948) and Bull et al. (1949) were among the first to emphasize the importance of a protein-free high-calorie diet in acute renal failure, and their original regimens contained both carbohydrate and fat. Fat, however, may cause nausea, diarrhoea, and fat pneumonia, and is little or no more effective in protein-sparing than carbohydrate. Because of toxic effects (Alexander & Zieve, 1961) , intravenous fat emulsions are best avoided in these patients.
As a result, Merrill (1965) has suggested that fat has no part to play in the treatment of uncomplicated renal failure, and that adequate quantities of carbohydrate should be given. For some time the commonest dietary regimen was 100 g of glucose given together with the daily allowance of 400 ml of water. Most patients will tolerate this mixture orally, although occasionally anti-emetic drug therapy may be required (Parsons, Blagg & Williams, 1963) . Recently, Wolthuis (1961) , after further studies on normal subjects, suggested that diet in acute renal failure should always supply more calories than 100 g of carbohydrate. Studies in patients with renal failure have given contradictory results. Gj0rup (1958) showed an apparent relationship between carbohydrate intake and protein-sparing but Bluemle et al. (1956) and Taylor (1957) could not confirm this. More recently Parsons & Fore (1963) (Butterfield, Sargeant & Whichelow, 1964) . Four bottles of this daily will provide 1700 calories with only 400 ml of water.
Occasionally patients may be unable to take calories by mouth and it is necessary to use the intravenous route but this is best avoided if possible because of risks of infection and thrombosis (Bansmer, Keith & Tesluk, 1958; Blagg, 1961) .
Other theoretical sources of non-protein calories are fructose and ethyl alcohol.
Anabolic steroids
The effect of androgenic hormones on protein metabolism is well known (Kochakian, 1946) . Selye (1940) and Masson, Cocoran & Page (1949) showed that testosterone propionate prolonged survival in nephrectomized animals, provided there was no infection. Testosterone and testosterone propionate have also been used in uraemic patients (Freedman & Spencer, 1957; Merrill, 1965) but usually the virilizing action outweighed any anabolic effect.
The synthesis of steroids with a greater anabolicandrogenic ratio re-awakened interest in their use in acute renal failure. We have shown (McCracken & Parsons, 1958; Blagg & Parsons, 1960) that norethandrolone is very effective in reducing urea formation in patients with post-partum renal failure and also in some patients with renal failure from other causes (Gj0rup & Thaysen, 1960; Blagg and Parsons, 1961) . Not all patients respond, particularly those with high rates of protein catabolism from trauma or infection, possibly because anabolic agents cannot prevent breakdown of devitalized tissue or are antagonized by excessive production of corticosteroids (Brochner-Mortensen, Gj0rup & Thaysen, 1959; Llaurado, Trunnell & Claus, 1960) . Wolthuis' work (1961) suggested that the proteinsparing action of carbohydrate and anabolic steroids is greater in well nourished subjects, and it is known that essential amino acids are necessary for nitrogen equilibrium (Rose, Coon & Lambert, 1954) . As a result, we have described balance studies showing that if patients with acute renal failure are fed protein rich in essential amino acids, together with an anabolic steroid, no significant increase in the rate of urea production occurs, as compared with the standard regimen, despite the increased protein intake, i.e. there is some improvement in protein balance (Blagg, Parsons & Young, 1962) . Similar results have also been described by Lawson et al. (1962 (Emerson, 1948) and for this reason, and because of the possible potassium content, transfused blood should be as fresh as possible. It is preferable to use packed cells rather than whole blood as the deficiency is of haemoglobin rather than plasma volume; in addition, old blood contains citrate which may bind calcium producing tetany and convulsions. Usually anaemia in these patients becomes stabilized, presumably because a balance occurs between marrow depression and haemolysis on the one hand and the stimulus to erythropoiesis from decreased oxygen carrying capacity on the other (Nathan et al., 1964 
Infection
The most common cause of death in patients with acute renal failure is bacterial infection (Balch, 1955; Parsons & McCracken, 1959; Maher & Schreiner, 1962) . Infection may enter from the site of trauma and it is known that both uraemia and malnutrition interfere with resistance to infection and wound healing. One of the dangers of infection is the resulting protein catabolism. The cause of the increased susceptibility to infection in these patients is unknown, as antibody production and phagocytosis are apparently normal (Balch, 1955 (Barnes et al., 1959) . Leucocytosis occurs commonly even in the absence of infection (Swan & Merrill, 1953) and fever may be absent (Shupack, Urichek & Merrill, 1960) making it difficult to diagnose infection.
When antibiotic treatment is given it should be remembered that in these patients antibiotics excreted primarily by glomerular filtration accumulate in the body producing much higher blood levels and the risk of toxic manifestations (Kunin et al., 1959) . This is particularly important with streptomycin, kanamycin and colistin (MacKay & Kaye, 1964) (Rath, Maillard & Schreiner, 1957 Thalhimer (1938) , are also ineffective because many of the substances accumulating in uraemia are distributed throughout the total body water. Blood has been circulated extracorporeally through ion exchange columns (Muirhead & Read, 1948) Kolobow & Dedrick (1966) and by Blaney, Lindan & Sparks (1966) , and the suggestion has been made by Chang (1966) (Haas, 1925) and of cellophane as a suitable membrane (Thalhimer, 1938) .
The first practical machine was produced by Kolff & Berk (1944 (Anderson & Kolff, 1959) . Alwall (1947) and Murray (1947) (Figs. 1 and 2 ). In these models ultrafiltration is possible since the membrane is supported and blood can be circulated under pressure.
Other machines include that of Inouye & Engelberg (1953) developed by Kolff & Watschinger (1956) In addition to correcting biochemical abnormalities it is sometimes necessary to remove water from the body of the patient with acute renal failure who has become overhydrated. Those dialysers in which the cellophane membrane is firmly supported are able to do this by the process of ultrafiltration in which the pressure in the blood line is raised thus producing a pressure gradient across the membrane.
One of the main disadvantages of the rotating coil type of machine is that ultrafiltration is impossible because the cellophane is not rigidly supported. As a result, fluid has to be removed by increasing the osmolality of the tank fluid using glucose, any hyperglycaemia occurring being controlled by the use of insulin (Lewis et al., 1952) . FIG. 3. Shunt. Connection of the patient to the artificial kidney
One of the problems in using the artificial kidney is connection of the apparatus to the patient. In the early days cannulae were inserted into an artery and vein in the forearm by surgical cut-down and removed after each dialysis. A great technical advance was the development of an indwelling shunt by Scribner's group (Scribner et al., 1960a; Quinton, Dillard & Scribner, 1962) (Fig. 3) (Kennedy et al., 1963; Peterson & Swanson, 1964) and increases in intracranial and intraocular pressure have been recorded during dialysis (Sitprija & Holmes, 1962) . It is therefore advisable to perform dialysis before gross biochemical changes develop so that large shifts of fluids and electrolytes do not occur.
Technical failure of the dialysis due to leaks occurring in the cellophane membrane or to clotting in the blood circuit are unusual and of no consequence provided that the amount of blood lost is negligible.
Peritoneal dialysis
The first experiments with peritoneal lavage were performed by Wegner (1877) and the technique was first used clinically by Ganter (1923) . Further refinements have since been made, particularly by Fine, Frank & Seligman (1946) and by Boen (1959 Boen ( , 1961 Boen ( , 1964 . The principle of peritoneal dialysis is the removal of solute and water by transfer across the peritoneum which acts as a semi-permeable membrane. Because of the simplicity of the technique and the development of commercially available packs peritoneal dialysis has become extremely popular in the last 4 or 5 years both as a means of treatment for acute renal failure and in the management of patients with chronic renal failure.
A plastic tube is introduced into the peritoneal cavity either through the trocar of a paracentesis set or, in the case of the latest catheter-the 'Trocath'-over a stylet, the stylet then being withdrawn (Fig. 4) . The catheter is connected to a container of dialysing solution, 2 litres of which are then run into the peritoneum. This is allowed to remain in the peritoneal cavity for a variable period of time in order to equilibrate and is then run out under gravity or with a small negative pressure pump. Dialysis occurs across the peritoneal membrane in the same fashion as across the cellophane membrane of the artificial kidney.
Commercially ter. Sodium and water can be removed very effectively and so peritoneal dialysis is often used for the treatment of overhydration. There is no necessity for priming with blood as with the artificial kidney and no necessity for the patient to be heparinized. Peritonitis or recent surgical operations are perhaps a partial contraindication to peritoneal dialysis, but nevertheless a number of workers have seen no harm result from its use in these circumstances (Burns et al., 1962) . Peritoneal dialysis is also useful in the treatment of acute poisoning with methyl alcohol or salicylates, particularly in children.
Indications for dialysis in acute renal failure
The artificial kidney is used to maintain life and well-being during periods of acute renal insufficiency, as originally suggested by Abel, Rowntree & Turner (1914) . Acute renal failure is frequently associated with severe infections and injury. Dialysis merely controls the chemical phenomena and has only indirect effects on these complications.
As recently as 1948 a Lancet editorial suggested that until artificial kidneys became safer they had no place in the treatment of acute renal failure. This view is no longer tenable. Dialysis, by improving biochemical abnormalities in the patient, improves the clinical state and so increases resistance to infection and other complications. It would therefore seem that the most appropriate use of the artificial kidney or peritoneal dialysis is the prevention of development of clinical symptoms due to uraemia. The clinical effects of uraemia are not well correlated with any of the biochemical abnormalities and our present view is that a blood urea concentration greater than 200 mg/100 ml is an indication for dialysis in the majority of patients with acute renal failure. Previous indications such as those of Kolff (1954) have now been discarded as a result of work such as that of Scribner & Caner (1960 ), Scribner, Magid & Burnell (1960b and Teschan, O'Brien & Baxter (1959) . By the use of early dialysis Parsons et al. (1961) (Jackson, 1959) . This is because too much attention has been paid in the past to the volume of urine formed rather than to the function which it represents. Correction of biochemical abnormalities at this stage depend upon the balance between endogenous production and available excretory capacity. When renal function is returning the concentration of urea in urine is approximately twice that of plasma (Bull et al., 1949) Other special indications for dialysis Dialysis has been used in the treatment of gout (Duncan et al., 1962 (Duncan et al., , 1963 Goldberg et al., 1962) .
In some patients with gout having such a degree of renal failure that they do not respond to uricosuric agents it has been shown that removal of uric acid by haemodialysis will diminish the size of tophi, improve the symptoms and occasionally increase responsiveness to the uricosuric drugs. Dialysis has also been used to treat the acidosis following paraldehyde ingestion (Beier, Pitts & Gonick, 1963) and to remove ethyl and methyl alcohol from patients.
Those interested in dialysis of poisons and drugs should consult the survey by Maher & Schreiner (1965 The recovery phase usually commences within 3 weeks of the initial injury, sometimes earlier and occasionally later. If there are no signs of increasing urine output after 3 weeks it is likely that the patient has a poor prognosis. In these circumstances it is justifiable to perform a renal biopsy so that the patient can either be considered for repeated chronic dialysis or treatment may be terminated.
During the recovery phase urinary losses of water and electrolytes may occur. These were emphasized in the past, probably because patients tended to be over-hydrated during the oliguric phase, and as a result considerable diuresis and electrolyte loss occurred at this time (Loughridge et al., 1960 (Swan & Merrill, 1953) Full recovery of normal health takes some [3] [4] [5] [6] months.
Prognosis in acute renal failure Prognosis of uncomplicated acute renal failure due to tubular necrosis is excellent. The majority of patients with renal failure following incompatible blood transfusion or post-partum haemorrhage will recover adequate renal function although slight impairment may persist for some time. For example, persistent impairment of PAH and inulin clearance have been described (Lowe, 1952; Finkenstaedt & Merrill, 1956 ) and histological changes in the glomerulus have also been described by Price & Palmer (1960) . The long-term prognosis in these patients is still uncertain. The prognosis in other cases of acute renal failure is frequently dependent on associated illness or injury which may determine whether the patient survives or not. Prophylactic dialysis often helps to prevent these complications becoming fatal, but Table 1 shows that even so the mortality of patients with renal failure following trauma remains high. This is because with improved resuscitation the more severely injured patient with multiple injuries survives to develop acute renal failure and then dies as a result of his original injury rather than renal failure. Table 2 summarizes the recovery rate in patients with renal failure treated in Leeds during the last 10 years.
